Neurodegenerative Disorders Clinical Trial
Official title:
Tau PET Imaging With 18F-T807(AV1451) in Neurodegenerative Disorders
Alzheimer's disease, Parkinson's disease, and Huntington's disease are common neurodegenerative diseases. Tau is a microtubule-associated protein, and aggregated tau resulting from hyperphosphorylation is a pathological feature of a group of neurodegenerative diseases known as tauopathies. The 18F-T807 (AV1451) molecular probe is a novel molecularly targeted imaging agent that exhibits high affinity and good selectivity for tau.
In this study, 18F-T807 (AV1451) molecular probe PET/CT was used to monitor the regional distribution and the degree of deposition in patients with neurodegenerative diseases, and compared with clinical symptoms to evaluate its value in the early differential diagnosis of neurodegenerative diseases. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT02823158 -
Bilateral Pallidal Stimulation in Patients With Advanced Parkinson's Disease-LATESTIM
|
N/A | |
| Withdrawn |
NCT02086240 -
Reproducibility of the 11C-PBR28 PET Signal
|
N/A | |
| Active, not recruiting |
NCT01589809 -
Effect of Nicotinamide in Friedreich's Ataxia
|
Phase 2 | |
| Recruiting |
NCT05394974 -
Joint Consultation Between a Neurologist and a Clinical Psychologist
|
||
| Recruiting |
NCT04684602 -
Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions
|
Phase 1/Phase 2 | |
| Completed |
NCT02860338 -
COMPARATIVE EFFECTIVENESS OF MCI and DEMENTIA TREATMENTS IN A COMMUNITY-BASED DEMENTIA PRACTICE
|
N/A | |
| Recruiting |
NCT05639140 -
A Registered Cohort Study on Color Discrimination Deficit Associated With Neurodegenerative Disorders.
|
||
| Recruiting |
NCT00149175 -
Clinical and Genetic Study of Neurodegenerative Disorders With Cognitive Impairment
|
Phase 1 | |
| Active, not recruiting |
NCT00874783 -
Development of iPS From Donated Somatic Cells of Patients With Neurological Diseases
|